NCT05438940

Brief Summary

The purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemotherapy and radiation treatment

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jul 2022Jun 2026

First Submitted

Initial submission to the registry

June 27, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

July 15, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2025

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 4, 2025

Status Verified

December 1, 2025

Enrollment Period

2.9 years

First QC Date

June 27, 2022

Last Update Submit

December 3, 2025

Conditions

Keywords

Nutrition Support

Outcome Measures

Primary Outcomes (5)

  • Recruitment Rate - Feasibility

    The study will be deemed feasible if ≥ 50% of eligible participants are enrolled

    12 Months

  • Retention Rate - Feasibility

    The study will be deemed feasible if ≥ 70% of participants enrolled at baseline will be retained at 8 weeks

    12 Months

  • Data Collection - Feasibility

    The study will be deemed feasible if ≥ 60% of participants submit 3/4 study assessments

    12 Months

  • Participant Satisfaction - Acceptability

    The study will be deemed acceptable if ≥ 70% of participants rate the overall intervention as satisfactory using a validated 4-item scale (score range 0-20).

    12 Months

  • Participant Rating on Ease of Use the Mobile Application - Usability

    The study will be deemed usable if ≥ 60% of participants rate the mobile application as easy-to-use for logging dietary intake using a validated 10-item scale (score range from 0-100).

    12 Months

Secondary Outcomes (2)

  • Participant Compliance with Dietician Visit - Intervention adherence

    12 Months

  • Participant Compliance with Dietary Log - Intervention adherence

    12 Months

Study Arms (1)

STRONG-GEC

EXPERIMENTAL

Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth and remote monitoring through a smart phone app and wearable sensor to allow participants to log food intake while sharing their data with a dietician.

Behavioral: Fitbit Data CollectionBehavioral: Nutrition CounselingBehavioral: Survey

Interventions

Participants will log food intake while sharing their data with a dietician in real time for 12 weeks

STRONG-GEC

Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth

STRONG-GEC
SurveyBEHAVIORAL

Participants will take a survey at baseline and weeks 4,8,12 \& 16. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

STRONG-GEC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old
  • Locally advanced or metastatic GEC diagnosis
  • Planned to initiate chemoradiation and/or radiation therapy with a plan to have surgery or a plan to have definitive treatment at Moffitt.
  • Able to speak and read English
  • Able to provide informed consent

You may not qualify if:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
  • Undergoing concurrent treatment for a secondary primary cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moffitt Cancer Center

Tampa, Florida, 33612, United States

Location

Related Publications (1)

  • Lin YC, Pimiento JM, Milano J, Riccardi D, Mckinnie N, Hume E, Sprow O, Diaz-Carraway S, Budnetz M, Hagen R, Al-Jumayli M, Pereira AL, Sinnamon AJ, Somasundaram A, Permuth JB, Tabriz AA, Turner K. Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer. Contemp Clin Trials Commun. 2024 Dec 23;43:101421. doi: 10.1016/j.conctc.2024.101421. eCollection 2025 Feb.

Related Links

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Kea Turner, PhD

    Moffitt Cancer Center

    PRINCIPAL INVESTIGATOR
  • Jose M Pimiento, MD

    Moffitt Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

June 30, 2022

Study Start

July 15, 2022

Primary Completion

June 4, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

December 4, 2025

Record last verified: 2025-12

Locations